This article has been updated to include the purchase price as disclosed in a regulatory filing.
 
NEW YORK (GenomeWeb News) – Third Wave Technologies said today that it has agreed to acquire Stratagene’s Full Velocity patents from Agilent Technologies.
 
In a filing with the US Securities and Exchange Commission, Third Wave said that it would pay Agilent $3.9 million, to be paid in quarterly installments over a period of three years with simple interest at an annual rate of 4.75 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.